Aware of the staffing challenges many colleagues were facing due to the pandemic, Melissa Olson decided to help out by creating her own relief service.
From Aug. 25 to Sept. 10, the Alberta College of Pharmacy will accept applications only for additional prescribing authorization as it gets ready to switch to a new electronic system.
Zuranolone is the first oral drug specifically designed for severe depression after childbirth, with relief that starts on Day 3 of a two-week regimen, according to clinical trial results.